Blood Cancers OncTalk 2024

Article and Video CATEGORIES

Cancer Journey

ABOUT

Dr. Sridevi Rajeeve is a hematologist-oncologist and physician-researcher specializing in plasma cell disorders and cellular therapies. Along with colleagues at Memorial Sloan-Kettering Cancer Center (MSK). Dr. Rajeeve offers a range of treatment options, including standard-of-care medications and cutting-edge clinical trials.

Blood Cancers OncTalk 2024

AlexandraGBeneke

Wed, 12/04/2024 - 12:21

The Blood Cancers OncTalk was a live, virtual, interactive patient education event hosted in October 2024 that included presentations and panel discussions covering general subjects relevant to a diverse range of blood cancers and treatment options and an opportunity to speak with the experts in a Q&A session.

Author

Sridevi Rajeeve, MD - Guest Faculty

This event was moderated by Dr. Sridevi Rajeeve, Memorial Sloan Kettering, joined by speakers: Dr. Hamza Hashmi, Memorial Sloan Kettering, Dr. Michele Stanchina, University of Miami, Dr. Muhammad Salman Faisal, Oklahoma University, and Dr. Andrew Srisuwananukorn, Ohio State University

Topics include:

- Myeloma 101: Facts and Fiction of the 'Myeloma Marathon'

- Updates in DLBCL

- Treatment Basics of Bone Marrow Transplant

- Frontline Therapies in Myelofibrosis

- Panel Discussions and a Question-and-Answer session

To watch the complete playlist, click here.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Leading Developments and Current Questions in Lung Cancer Panel Discussions

Video

In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.

Bladder Cancer Video Library 2024

Video

Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.

Case Based Panel Discussions 2024

Video

The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.